These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7525155)

  • 1. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 3. [Donors blood screening and prevention of posttransfusion type C hepatitis in Japan].
    Yoshizawa H
    Uirusu; 1993 Dec; 43(2):315-21. PubMed ID: 7510090
    [No Abstract]   [Full Text] [Related]  

  • 4. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1998; (62):237-49. PubMed ID: 9507813
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
    Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
    Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HCV screening of blood donors: the impact in Spain.
    Koff RS
    Gastroenterology; 1991 Mar; 100(3):839-41. PubMed ID: 1847120
    [No Abstract]   [Full Text] [Related]  

  • 7. Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis.
    Mazda T; Nakata K; Bannai M; Miyamura T; Chiba J; Ohba H; Kaminuma Y; Katayama T
    Transfus Med; 1993 Jun; 3(2):149-51. PubMed ID: 7690640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the c100 antigen be removed from HCV antibody assays?
    Zaaijer HL; Cuypers HT; Reesink HW; Lelie PN
    Vox Sang; 1994; 66(2):150. PubMed ID: 7514326
    [No Abstract]   [Full Text] [Related]  

  • 9. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
    Takano S; Omata M; Ohto M; Nakamura K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus antibodies and virus replication in asymptomatic blood donors.
    Yuki N; Hayashi N; Hagiwara H; Naito M; Ohkawa K; Kasahara A; Fusamoto H; Ohtani S; Okubo Y; Kamada T
    Vox Sang; 1994; 67(3):280-5. PubMed ID: 7532341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
    Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
    Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstrating antibodies against hepatitis C virus in transfusion practice. Viral Hepatitis Working Group of the Société Française de la Transfusion Sanguine].
    Maisonneuve P; Noël L
    Transfus Clin Biol; 1994; 1(5):397-400. PubMed ID: 7529098
    [No Abstract]   [Full Text] [Related]  

  • 15. HCV and blood transfusion.
    Reesink HW; van der Poel CL; Cuypers HT; Lelie PN
    Arch Virol Suppl; 1992; 4():241-3. PubMed ID: 1280507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of transfusion-acquired hepatitis C.
    Wreghitt TG; Gandhi MK; Gray JJ; Blagdon J; Rankin A; Coates PB
    Clin Lab Haematol; 1993; 15(2):141-4. PubMed ID: 7688679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients.
    Mihaljević I; Feldbauer J; Delajlija M; Grgicević D
    Vox Sang; 1992; 63(3):236. PubMed ID: 1333138
    [No Abstract]   [Full Text] [Related]  

  • 18. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 19. Posttransfusion hepatitis in Japan.
    Takano S; Omata M; Ohto M; Satomura Y
    Vox Sang; 1992; 62(3):156-64. PubMed ID: 1609517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are synthetic peptides sensitive enough for screening anti-hepatitis C virus at blood banks?
    León P; López JA; Elola C; Domingo CJ; Echevarría JM
    Vox Sang; 1994; 67(1):83-4. PubMed ID: 7526551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.